tenofovir has been researched along with Osteoporotic Fractures in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 3 (37.50) | 2.80 |
Authors | Studies |
---|---|
Chang, JI; Cho, YY; Jang, ES; Kim, E; Kim, HJ; Kim, SS; Lee, HW; Seo, GH; Yoon, E | 1 |
Adams-Huet, B; Bedimo, RJ; Maalouf, NM; Moore-Matthews, D; Nguyen, V; Poindexter, J | 1 |
Beaubrun, A; Cummings, TH; Hardin, JW; Hsu, LI; Magagnoli, J; Majethia, S; Sutton, SS | 1 |
Angeli, P; Fasolato, S; Gambino, C; Mareso, S; Piano, S; Pilutti, C; Pontisso, P; Romano, A; Sartori, L; Stanco, M; Tonon, M | 1 |
Dong, Y; Gedmintas, L; Katz, JN; Lehmann, E; Losina, E; Solomon, DH; Wright, EA | 1 |
Lane, JM; Rebolledo, BJ; Unnanuntana, A | 1 |
Bedimo, R; Drechsler, H; Maalouf, NM; Tebas, P; Zhang, S | 1 |
Powderly, WG | 1 |
1 review(s) available for tenofovir and Osteoporotic Fractures
Article | Year |
---|---|
Osteoporosis and bone health in HIV.
Topics: Absorptiometry, Photon; Acquired Immunodeficiency Syndrome; Adenine; Alcohol Drinking; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Bone Density; Bone Density Conservation Agents; Female; Humans; Inflammation; Male; Organophosphonates; Osteomalacia; Osteoporosis; Osteoporotic Fractures; Smoking; Tenofovir; Weight Loss | 2012 |
7 other study(ies) available for tenofovir and Osteoporotic Fractures
Article | Year |
---|---|
Tenofovir disoproxil fumarate versus tenofovir alafenamide on risk of osteoporotic fracture in patients with chronic hepatitis B: A nationwide claims study in South Korea.
Topics: Adenine; Adult; Alanine; Female; Hepatitis B, Chronic; Humans; Male; Middle Aged; Osteoporotic Fractures; Retrospective Studies; Tenofovir | 2023 |
Changes in bone microarchitecture with abacavir--lamivudine versus tenofovir disoproxil fumarate--emtricitabine in adults living with HIV.
Topics: Absorptiometry, Photon; Adult; Anti-HIV Agents; Dideoxynucleosides; Drug Combinations; Emtricitabine; Fractures, Bone; HIV Infections; Humans; Incidence; Lamivudine; Osteoporotic Fractures; Tenofovir | 2020 |
Association of tenofovir disoproxil fumarate exposure with chronic kidney disease and osteoporotic fracture in US veterans with HIV.
Topics: Adult; Aged; Anti-HIV Agents; Cohort Studies; Female; HIV Infections; Humans; Logistic Models; Male; Middle Aged; Osteoporotic Fractures; Renal Insufficiency, Chronic; Tenofovir; Veterans | 2020 |
Assessment of bone mineral density in patients with cirrhosis treated with third-generation nucleos(t)ide analogues: comparison between tenofovir and entecavir.
Topics: Absorptiometry, Photon; Adolescent; Adult; Aged; Antiviral Agents; Bone Density; Female; Guanine; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Male; Middle Aged; Osteoporosis; Osteoporotic Fractures; Parathyroid Hormone; Prospective Studies; Risk Assessment; Tenofovir; Vitamin D Deficiency; Young Adult | 2018 |
Factors associated with fractures in HIV-infected persons: which factors matter?
Topics: Adult; Anti-HIV Agents; Bone Density; CD4 Lymphocyte Count; Female; Hepatitis C, Chronic; HIV Infections; Humans; Male; Massachusetts; Middle Aged; Osteoporotic Fractures; Retrospective Studies; Risk Factors; Tenofovir | 2017 |
Bilateral pathologic hip fractures associated with antiretroviral therapy: a case report.
Topics: Accidental Falls; Adenine; Alendronate; Anti-HIV Agents; Bone Density Conservation Agents; Comorbidity; Fanconi Syndrome; Female; Femoral Neck Fractures; Fractures, Spontaneous; Hip Fractures; HIV Infections; Humans; Magnetic Resonance Imaging; Middle Aged; Organophosphonates; Osteoporotic Fractures; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Failure | 2011 |
Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents.
Topics: Adenine; Adolescent; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; Hip Fractures; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Male; Middle Aged; Organophosphonates; Osteoporotic Fractures; Retrospective Studies; Risk; Risk Factors; Ritonavir; Spinal Fractures; Tenofovir; Time Factors; Treatment Outcome; Wrist Injuries; Young Adult | 2012 |